Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1282520-89-1

Post Buying Request

1282520-89-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1282520-89-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1282520-89-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,2,5,2 and 0 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1282520-89:
(9*1)+(8*2)+(7*8)+(6*2)+(5*5)+(4*2)+(3*0)+(2*8)+(1*9)=151
151 % 10 = 1
So 1282520-89-1 is a valid CAS Registry Number.

1282520-89-1Relevant articles and documents

Discovery of a novel phenylethyl benzamide glucokinase activator for the treatment of type 2 diabetes mellitus

Park, Kaapjoo,Lee, Byoung Moon,Kim, Young Hwan,Han, Taedong,Yi, Wonhui,Lee, Dong Hoon,Choi, Hyun Ho,Chong, Wonee,Lee, Chun Ho

, p. 537 - 542 (2013)

Novel benzamide derivatives were synthesized and tested at in vitro assay by measuring fold increase of glucokinase activity at 5.0 mM glucose concentration. Among the prepared compounds, YH-GKA was found to be an active glucokinase activator with EC50 of 70 nM. YH-GKA showed similar glucose AUC reduction of 29.6% (50 mg/kg) in an OGTT study with C57BL/J6 mice compared to 29.9% for metformin (300 mg/kg). Acute treatment of the compound in C57BL/J6 and ob/ob mice elicited basal glucose lowering activity. In subchronic study with ob/ob mice, YH-GKA showed significant decrease in blood glucose levels and no adverse effects on serum lipids or body weight. In addition, YH-GKA exhibited high bioavailability and moderate elimination in preclinical species.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1282520-89-1